Treatment of refractory chronic graft-versus-host disease with Imatinib: a single center experience

被引：0

作者：

Carrillo Checa, Javier ^{[1
]}

Rivera Delgado, Daniel Esteban ^{[1
]}

Avendano Pita, Alejandro ^{[1
]}

Presa Morales, Daniel ^{[1
]}

Sobejano Fuertes, Eduardo ^{[1
]}

Higuero Saavedra, Victor ^{[1
]}

Arratibel Zalacain, Nerea ^{[1
]}

Baile Gonzalez, Monica ^{[1
]}

Veiga Vaz, Alvaro ^{[1
]}

Lopez Cadenas, Felix ^{[1
]}

Martin Lopez, Ana A. ^{[1
]}

Perez Lopez, Estefania ^{[1
]}

Cabrero Calvo, Monica ^{[1
]}

Vazquez Lopez, Lourdes ^{[1
]}

Sanchez Guijo, Fermin ^{[1
]}

Caballero Barrigon, Maria Dolores ^{[1
]}

Lopez Corral, Lucia ^{[1
]}

机构：

[1] Complejo Asistencial Univ Salamanca IBSAL, Hematol, Salamanca, Spain

来源：

BONE MARROW TRANSPLANTATION | 2018年 / 53卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P420

引用

页码：460 / 461

页数：2

共 50 条

[21] DASATINIB AS SALVAGE THERAPY FOR IMATINIB-REFRACTORY SCLEROTIC CHRONIC GRAFT-VERSUS-HOST DISEASE
Sanchez-Ortega, I.
Servitje, O.
Penin, R.
Peralta, T.
Patino, B.
Duarte, R.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 647 - 647
[22] Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: a single-center experience
Niittyvuopio, Riitta
Juvonen, Eeva
Heiskanen, Jouni
Lindstrom, Vesa
Nihtinen, Anne
Sahlstedt, Leila
Volin, Liisa
TRANSFUSION, 2018, 58 (08) : 1973 - 1979
[23] The Treatment of Chronic Graft-Versus-Host Disease
Wolff, Daniel
Bertz, Hartmut
Greinix, Hildegard
Lawitschka, Anita
Halter, Joerg
Holler, Ernst
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2011, 108 (43): : 732 - I
[24] Ruxolitinib in Chronic Graft Versus Host Disease: Single Center Experience
Atesoglu, Elif Birtas
Dora, Imran
Eren, Cigdem
Celik, Suat
Kusdemir, Gokhan
Cekdemir, Demet
Caliskan, Kader
Gulbas, Zafer
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 375 - 376
[25] CLINICAL EVOLUTION OF PATIENTS WITH GRAFT-VERSUS-HOST DISEASE - THE EXPERIENCE OF A SINGLE CENTER
Salselas, Ana
Leite-Silva, Pedro
Lopes, Sara
Vieira, Lucia
Roncon, Susana
BONE MARROW TRANSPLANTATION, 2024, 59 : 346 - 346
[26] Infliximab for treatment of steroid refractory acute and chronic graft-versus-host disease
Trenschel, R
Trampenau, C
Ditschkowski, M
Elmaagacli, A
Ottinger, H
Steckel, N
Biersack, H
Peceny, R
Beelen, D
BONE MARROW TRANSPLANTATION, 2003, 31 : S128 - S129
[27] URSODEOXYCHOLIC ACID TREATMENT OF REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE OF THE LIVER
FRIED, RH
MURAKAMI, CS
FISHER, LD
WILLSON, RA
SULLIVAN, KM
MCDONALD, GB
ANNALS OF INTERNAL MEDICINE, 1992, 116 (08) : 624 - 629
[28] Topical cyclosporine for treatment of refractory ocular chronic graft-versus-host disease
Rzepecki, P
Sarosiek, T
Langiewicz, P
Zolnierek, J
Szczylik, C
BONE MARROW TRANSPLANTATION, 2006, 37 : S96 - S96
[29] Promising efficacy of Ibrutinib in the treatment of Chronic refractory graft-versus-host disease
Stocker, Nicolas
HEMATOLOGIE, 2018, 24 (01): : 21 - 22
[30] Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
Willenbacher, W
Basara, N
Blau, IW
Fauser, AA
Kiehl, MG
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 820 - 823

← 1 2 3 4 5 →